Comprehensive panels
Comprehensive genomic profiling (CGP) uses a single assay to assess hundreds of genes, including relevant cancer biomarkers, for biomarker discovery and other research aims.
Streamline oncology clinical research with Illumina Connected Insights
Comprehensive insights and automation to support variant interpretation for diverse applications and variant types at scale
Your email address is never shared with third parties.
The Connected Insights software harnesses extensive knowledge sources via powerful API-integrations for streamlined variant interpretation, including prioritization of relevant clinical trials, drug labels, and guidelines for clinical research. Control over your standardized workflows enables flexibility, and automation speeds your time to relevant insights with procedural consistency. Connected Insights helps you address the interpretation bottleneck and move our understanding of disease forward.
Harness the power of integrated knowledge sources into a single solution to bring insights to diverse applications. Automate your interpretation workflows with customizable presets.
Remove unnecessary touchpoints and manual data movement for your NGS workflow, from sequencing through draft report. Seamless and secure, upstream and downstream, directly integrate with the latest DRAGEN secondary analysis.
Keep pace with comprehensive test options that enable diverse variant and biomarker analyses. Expand assay applications and scale volume without increasing headcount and interpretation resources.
Generate insights from 55+ knowledge sources including the Clinical Knowledgebase (CKB) from Genomenon, CiVIC, and OncoKB.
Grow and manage your lab's private curated knowledge.
From data upload, automated guidelines-based oncogenicity classification, to report generation – configure your settings and automate for a streamlined experience with minimum touchpoints.
Evolve with confidence across assays and applications—from panels to genomes and transcriptomes, from tissue to liquid biopsy and heme.
Configure regional content, preferences and language to meet regional needs.
Employ security-first infrastructure and conform to privacy and compliance software requirements and regulations.
Identify key DNA variant types (SVs, MNVs, exon-level CNVs, indels, fusions, tandem repeats, LOH) relevant in multiple disease types and across a variety of NGS assays.
Analyze variants from RNA or transcriptomics (fusions, splice variants, and soon expression levels) to gain a deeper and more comprehensive understanding of malignancies.
Uncover more insights by interpreting genome- wide pan-cancer biomarker signatures (TMB, MSI, HRD) with increasing relevance to precision medicine.
Rapid, interpretable data for meaningful insights
Prepare libraries for somatic oncology panels, CGP, or other compatible applications.
Sequence libraries using any Illumina or other sequencing platform.
Call variants with DRAGEN or other secondary analysis tools to generate VCF (Variant Call Format) output.
Ingest VCF files to Connected Insights to enable generation of insights and case reporting.
Tertiary analysis software can help address the bottleneck for somatic oncology variant interpretation. Learn key considerations and best practices for implementing a streamlined workflow.
Your email address is never shared with third parties.
To meet the most stringent security requirements, Illumina Connected Insights platform is built with security and compliance at its core. Read the security brief for more details.
The Connected Insights cloud platform directly integrates within an Illumina Connected Software ecosystem, unifying highly scalable data management and processing with enterprise-level data privacy and security features all within a single environment. A direct integration option with DRAGEN for variant calling is seamless and automated.
The Connected Insights on-premises supports customers in environments where access to the cloud is not an option, offering a solution for local variant calling and interpretation for somatic oncology applications. Accessed via a DRAGEN server, users can directly pair DRAGEN secondary analysis with Connected Insights.
Read about the joint power of DRAGEN and Connected Insights-Local:
Configure once with a fine level of granularity to match your lab’s standard operating procedure (SOP). Accelerate your workflow by leveraging automation configured according to your SOP.
Grow your lab’s private knowledge base with every case and instantly interpret cases against your historical experience. Your curated knowledge is private, secure, and always at your fingertips.
Customize based on lab name, lab branding, sections, fields, and more. Easily edit reports without data reingestion. Export reports to a chosen language.
Save time with automated data upload after one-time configuration. Enjoy workflows with no touchpoints from Illumina sequencers.
Quickly view key findings, coverage, and QC summary in a consolidated format. Intuitively access deeper evidence sources with a streamlined user interface design.
Accelerate turnaround time by automating your exact SOP from variant QC and prioritization to interpretation and reporting by configuring disease, guideline, and lab-specific settings.
Deepen your insights with cutting-edge visualizations –explore genome view, DNA and RNA coverage plots, variant allele frequency (VAF), fusion plots, and more.
Discover how the Connected Insights can streamline user-defined variant interpretation research workflows and reduce the time it takes to generate meaningful insights, all with a single-vendor workflow.
Watch this video to understand how the Connected Insights can connect various knowledge sources to streamline data interpretation operations for critical insights.
Read how Connected Insights streamlines, integrates, and powers molecular laboratories for scale and growth.
Key opinion leaders discuss the ongoing challenges and future potential of NGS in clinical oncology.
Learn how Connected Insights employs key security and privacy features to protect sensitive NGS data.
View the software resources page for the latest release information and other news.
Comprehensive genomic profiling (CGP) uses a single assay to assess hundreds of genes, including relevant cancer biomarkers, for biomarker discovery and other research aims.
Focus on sequencing coding regions, which frequently contain mutations that affect tumor progression, for a cost-effective approach.
Get a genome-wide view of somatic mutations and other genomic alterations present in cancer tissue and discover novel cancer-associated variants.
Discuss your workflow to learn how you can streamline your NGS operations and power your lab for growth using Illumina Connected Insights.
Your email address is never shared with third parties.